Amanta Healthcare IPO
Bookbuilding IPO | ₹126.00 Cr | Listing at BSE, NSE
IPO Open
Mon, Sep 01, 2025
IPO Close
Wed, Sep 03, 2025
Price Band
₹120.00 to ₹126.00
Market Cap (Pre-IPO)
₹489.25 Cr
IPO Details
| IPO Date | Sep 01, 2025 to Sep 03, 2025 |
| Listing Date | Tentative: Sep 09, 2025 |
| Face Value | ₹10.00 per share |
| Price Band | ₹120.00 to ₹126.00 |
| Lot Size | 119 Shares (Minimum: ₹14,994.00) |
| Sale Type | Fresh Issue |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Issue Size | ₹126.00 Crores |
| Total Shares Offered | 10,000,000 shares |
| Offer For Sale | 10,000,000 shares |
Subscription Data
| Category | Times Subscribed |
|---|---|
| QIB | 35.86x |
| NII | 209.40x |
| RII | 54.96x |
| Total | 82.60x |
Amanta Healthcare IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | 50,00,000 (50.00%) |
| Retail Shares Offered | 35,00,000 (35.00%) |
| NII Shares Offered | 15,00,000 (15.00%) |
Amanta Healthcare IPO Lot Size
Investors can bid for a minimum of 119 shares and in multiples thereof
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹194,922 |
| S-HNI (Min) | 14 | 1,666 | ₹209,916 |
| S-HNI (Max) | 66 | 7,854 | ₹989,604 |
| B-HNI (Min) | 67 | 7,973 | ₹1,004,598 |
Amanta Healthcare Financial Information (Restated Consolidated)
Amanta Healthcare Ltd.'s revenue decreased by 2% and profit after tax (PAT) rose by 189% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| NET Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
Amount in ₹ Cr
Key Performance Indicators
As of Monday, March 31, 2025| KPI | Values |
|---|---|
| ROE (Return on Equity) | 12.42% |
| ROCE (Return on Capital Employed) | 13.72% |
| Debt/Equity | 2.02 |
| RoNW (Return on Net Worth) | 10.89% |
| PAT Margin (Profit After Tax Margin) | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 3.64 | 2.70 |
| P/E (x) | 34.59 | 46.59 |
| Promoter Holding | 85.60% | 63.56% |
Company Promoters
- The promoters of the Company are Bhavesh Patel
- Vishal Patel
- Jayshreeben Patel
- Jitendra Kumar Patel and Milcent Appliances Private Limited.
Company Overview
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company markets products through three business units:
- National sales,
- International sales and
- Product partnering with various foreign and Indian pharmaceutical companies.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.
Company Strengths
- Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
- Large manufacturing capabilities
- Wide Domestic and International Marketing Network.
- Experienced management team supported by a large, diverse and skilled workforce.
Use of Proceeds
| 1) | Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | 70.00 |
| 2) | Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | 30.13 |
| 3) | General corporate purposes | 6.60 |
Objectives
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
Amanta Healthcare IPO Peer Comparison
Amanta Healthcare peer comparison with similar listed entities. (As on March 31, 2025)| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Amanta Healthcare Limited | 3.71 | 3.71 | 33.43 | 33.92 | 10.89 | 3.82 | - |
| Denis Chem Lab Ltd | 5.82 | 5.82 | 61.33 | 15.92 | 9.49 | 1.51 | Standalone |
Quick Info
| Sector | Pharmaceuticals |
| Exchange | BSE, NSE |
| Market Cap (Pre-IPO) | ₹489.25 Cr |
| GMP | 0.00 |
Important Dates
| IPO Open | Sep 01, 2025 |
| IPO Close | Sep 03, 2025 |
| Allotment Date | Sep 04, 2025 |
| Credit to Demat | Sep 08, 2025 |
| Listing Date | Tentative: Sep 09, 2025 |
Lead Manager(s)
Beeline Capital Advisors Pvt.Ltd.
Registrar
Description
- Amanta Healthcare IPO is a book build issue of ₹126.00 crores. The issue is entirely a fresh issue of 1.00 crore shares of ₹126.00 crore.
- Amanta Healthcare IPO bidding started from Sep 1, 2025 and ended on Sep 3, 2025. The allotment for Amanta Healthcare IPO was finalized on Sep 4, 2025. The shares got listed on BSE, NSE on Sep 9, 2025.
- Amanta Healthcare IPO price band is set at ₹126.00 per share . The lot size for an application is 119. The minimum amount of investment required by an retail is ₹14,994 (119 shares) (based on upper price). The lot size investment for sNII is 14 lots (1,666 shares), amounting to ₹2,09,916, and for bNII, it is 67 lots (7,973 shares), amounting to ₹10,04,598.